New generic combo pill for high blood pressure put to the test
NCT ID NCT07584304
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will check if a new generic drug called YHP2508C works the same as the reference drug YHR2603 in 44 healthy adults. Participants will take a single dose of each drug under fasting conditions, and researchers will measure drug levels in the blood. The goal is to see if the generic version is bioequivalent, meaning it delivers the same amount of active ingredients into the body.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
YHP2508C (a combination of amlodipine, telmisartan, and chlorthalidone)
What this could lead to
If successful, this could show that the test drug is a safe and effective generic alternative to the reference drug, potentially offering a lower-cost treatment option for high blood pressure.
What could go wrong
This is an early-phase bioequivalence study in healthy volunteers, not patients. It only measures how the drug is absorbed and processed, not whether it works for the intended condition. Results may not predict real-world effectiveness or safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••